ISDA: 4G11

Deposition Date 2012-07-10

Release Date 2012-11-14

Last Version Date 2023-09-13

Entry Detail

PDB ID:

4G11

Keywords:

Transferase/Transferase Inhibitor

Title:

X-ray structure of PI3K-gamma bound to a 4-(morpholin-4-yl)- (6-oxo-1,6-dihydropyrimidin-2-yl)amide inhibitor

Biological Source:

Source Organism(s):

Homo sapiens (Taxon ID: 9606)

Expression System(s):

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

3.40 Å

R-Value Free:

0.34

R-Value Work:

0.28

R-Value Observed:

0.28

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
Gene (Uniprot):PIK3CG
Chain IDs:A
Chain Length:966
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P48736 Pfam ID:PF00794, PF00792, PF00613, PF00454 EC:2.7.1.137

Ligand Molecules

0W7

Primary Citation

Preparation and optimization of new 4-(morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives as PI3K beta inhibitors

Certal, V, Halley, F, Virone-Oddos, A, Thompson, F, Filoche-Romme, B, El-Ahmad, Y, Carry, J.C, Delorme, C, Karlsson, A, Abecassis, P.Y, Vincent, L, Bonnevaux, H, Nicolas, J.P, Morales, R, Michot, N, Vade, I, Louboutin, A, Perron, S, Doerflinger, G, Tric, B, Monget, S, Lengauer, C, Schio, L.Show

Bioorg.Med.Chem.Lett. 22 6381 6384 (2012)

PMID: 22981333 DOI: 10.1016/j.bmcl.2012.08.072

Abstact

From a HTS campaign, a new series of pyrimidone anilides exemplified by compound 1 has been identified with good inhibitory activity for the PI3Kβ isoform. The structure of compound 1 in PI3Kγ was solved revealing a binding mode in agreement with the SAR observed on PI3Kβ. These compounds displayed inhibition in the nanomolar range in the biochemical assay and were also potent p-Akt inhibitors in a PTEN-deficient PC3 prostate cancer cell line. Optimization of in vitro pharmocokinetic properties led to compound 25 exhibiting 52% bioavailability in mice and target engagement in an acute PK/PD study.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form